Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 7/20 | 0.54 |
| ▸ | PTGIR | P43119 | 10/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9014266 | 1.00 | TBXAS1 (0.54) | TBXAS1PTGIRKDM4CTBXA2R | |
| SCHEMBL9014264 | 1.00 | TBXAS1 (0.54) | TBXAS1PTGIRKDM4CTBXA2R | |
| SCHEMBL9014188 | 0.87 | TBXAS1 (0.56) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014478 | 0.87 | TBXAS1 (0.58) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014474 | 0.87 | TBXAS1 (0.58) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014191 | 0.87 | TBXAS1 (0.56) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014480 | 0.87 | TBXAS1 (0.58) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014187 | 0.87 | TBXAS1 (0.56) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014496 | 0.86 | TBXAS1 (0.64) | TBXAS1PTGIRKDM4C | |
| SCHEMBL9014632 | 0.86 | TBXAS1 (0.73) | TBXAS1PTGIRKDM4CTBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0581187-B1 | Oxime derivatives | ONO PHARMACEUTICAL CO (JP) | 1996-12-04 | — | — | EP | disclosed |
| US-5480998-A | Oxime derivative | ONO PHARMACEUTICAL CO., LTD. (JP) | 1996-01-02 | — | — | US | disclosed |
| EP-0581187-A1 | Oxime derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1994-02-02 | — | — | EP | disclosed |